Cyvex Nutrition has been issued a Notice of Allowance from the U.S. Patent and Trademark Office for a patent relating to its use of Cognisetin, a fisetin-based ingredient believed to enhance long-term memory.
Cyvex Nutrition (Irvine, CA) has been issued a Notice of Allowance from the U.S. Patent and Trademark Office for a patent relating to its use of Cognisetin, a fisetin-based ingredient believed to enhance long-term memory.
The patent relates to the ingredient’s use of flavonoids to enhance memory.
“The patent describes fisetin as a neuroprotector capable of generating neuron cells in the presence of damage, promoting antioxidant synthesis, and reducing overactive brain-and spinal cord-specific immune defenses that contribute to age-related decline and/or conditions,” said the company in a recent statement.
Matt Phillips, president and CEO of Cyvex Nutrition says that the patent “…validates Cognisetin’s status as a genuinely novel ingredient with a clinically-backed cognitive health benefit.”
The Nutritional Outlook Podcast Episode 33: Keeping up with contract manufacturing
July 26th 2024Nutritional Outlook talks to Lauren Samot, commercial innovation leader, and Blayney McEneaney, sales executive at Vitaquest International, about trends within the contract manufacturing space, and the ways in which contract manufacturers like Vitaquest keep up with the market and differentiate themselves from the competition.